Jeffrey J. Brown - 16 Jun 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
21 Jun 2022, 21:16:06 UTC
Previous filing
11 May 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $0 +1,580 +207% $0.000000 2,345 16 Jun 2022 Direct F1
holding MED Common Stock 35,539 16 Jun 2022 Brown Equity Partners, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the right to receive 1,580 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023.
F2 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.